Disclosure Panels Details Page
Prostate Cancer Early Detection Panel - Disclosures as of 10/12/2015
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Gerald Andriole MD | None | None | Augmenix Bayer HealthCare Genomic Health, Inc. GSK Medivation Myriad Genetic Laboratories, Inc. |
None | - |
| Robert Bahnson MD | None | Various Law Firms | None | None | - |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| Peter Carroll MD, MPH | Department of Defense Genomic Health, Inc. Myriad Genetic Laboratories, Inc. National Cancer Institute |
None | None | None | ✔ |
| Erik Castle MD | None | Bayer HealthCare | None | None | ✔ |
| William Catalona MD | Beckman-Coulter, Incorporated deCODE genetics, Inc Ohmx |
Beckman Coulter Inc deCODE genetics Ohmx |
Beckman-Coulter, Inc Ohmx, Inc |
Ohmx Inc | - |
| Douglas Dahl MD | None | None | None | None | ✔ |
| John Davis MD | Genome DX Genprobe Janssen Pharmaceutica Products, LP Mimedx Myriad Genetic Laboratories, Inc. |
Astellas Pharma US, Inc. | Springer U.S. | None | - |
| Jonathan Epstein MD | None | None | aperio dianon metamark genetics |
None | ✔ |
| Ruth Etzioni PhD | None | None | None | None | ✔ |
| Thomas Farrington BSEE | None | None | None | None | ✔ |
| Deborah Freedman-Cass PhD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| George Hemstreet III MD, PhD | None | None | None | None | ✔ |
| Mark Kawachi MD | None | None | None | None | - |
| Simon Kim MD, MPH | NA | NA | NA | NA | - |
| Paul Lange MD | None | None | None | None | ✔ |
| Kevin Loughlin MD | None | None | None | None | ✔ |
| William Lowrance MD, MPH | Argos Therapeutics GenomeDx Myriad Genetic Laboratories, Inc. National Cancer Institute |
MDxHealth | None | None | ✔ |
| Paul Maroni MD | None | None | None | None | - |
| Joan McClure MS | None | None | None | None | - |
| James Mohler MD | National Cancer Institute | Genomic Health, Inc. | None | Androbiosys, Inc. | ✔ |
| Todd Morgan MD | MDxHealth Myriad Genetic Laboratories, Inc. |
MDxHealth Myriad Genetic Laboratories, Inc. |
None | None | ✔ |
| Kelvin Moses MD, PhD | None | Nutech Biomarkers | None | None | ✔ |
| Robert Nadler MD | None | None | None | None | ✔ |
| J. Kellogg Parsons MD, MHS | National Cancer Institute | MDx Health | None | None | ✔ |
| Michael Poch MD | None | None | None | None | ✔ |
| Charles Scales MD | None | None | None | None | - |
| Terrence Shaneyfelt MD, MPH | None | None | None | None | - |
| Dottie Shead MS | None | None | None | None | ✔ |
| Marc Smaldone MD, MSHP | None | None | None | None | - |
| Geoffrey Sonn MD | None | None | None | None | ✔ |
| Preston Sprenkle MD | None | None | None | None | ✔ |
| Andrew Vickers PhD | National Cancer Institute | COONEY, SCULLY AND DOWLING Opko diagnostics |
GenomeDX | Arctic Partners|OPKO | - |
| Robert Wake MD | None | None | None | None | ✔ |